The mild ester-based antimicrobial systems market is projected to grow from USD 21.3 million in 2025 to USD 46.0 million by 2035, at a CAGR of 8.0%. Skin Care will dominate with a 10.1% market share, while powder will lead the product form segment with a 15.8% share.